Get your free subscription to PharmaVOICE Magazine
Click one of the links below to pick what type of subscription you’d like. It’s completely free.
Click here to login
Have a Question?
Email Customer Service
Remember your password?
Click here to login.
Have a Question?
Contact Customer Service
Read the Digital Edition
FEATURED CONTRIBUTED CONTENT
The emergence of digital pathology presents an opportunity for central laboratories to support highly targeted therapeutics and precision medicine even further, offering many advantages to both diagnostic and clinical trials testing. This paper explains the noteworthy progress in the industry’s wider acceptance of digital pathology systems and its many benefits. There is also a related [ ]
In this episode, Dr. Matthew Turner talks about trends in Digital Pathology, and how this new research tool can benefit sponsors, CROs, and Pathologists. There is also a related white paper, entitled, How Digital Pathology is Revolutionizing Clinical Trials, which you can download using the link below.
Drug development costs for Central Nervous System (CNS) trials are more complex and costly for pharmaceutical companies and often take longer to develop than other medicines. Failed studies often occur later in development when costs are the highest. For compound efficacy and safety that is being measured with electroencephalography (EEG), technical and recording difficulties simply [ ]
The term customer experience (CX) might be relatively new in pharma but the reality is as old as the industry itself. Every time a company interacts with a customer, it is delivering some sort of customer experience. In our increasingly multi-stakeholder and multichannel world, pharma companies must get comfortable with the idea that CX is not a linear, [ ]
In the life science industry, demand is exploding for evidence generated through real-world data. Unfortunately, most companies haven’t significantly updated their methods for generating evidence in the past 25 years. Are you ready to handle the disruption? This ebook covers numerous issues from a variety of stakeholders, including data visualization capabilities, advanced analytics, rich data [ ]
In the November issue of The Evidence Forum, one of the informative articles covers patient engagement and retention, two key issues in clinical studies. We’ve all heard the buzz about patient-centricity. In this article, learn how a patient-centric approach can improve patient engagement and retention. Here is a sample of what you will see in [ ]
New Manatt Health Webinar Reveals the Megatrends Reinventing the Ways Your Patient, Provider and Payer Customers Think—and How You Should Respond to Succeed. Click to Register Free. From the continued evolution of new payment models to the explosion of mHealth to the creation of personalized therapies, powerful trends and disruptive innovations are converging to reshape [ ]
Ensuring a patient-first strategy drives real results in commercial pharma Does patient centricity work? Actually, yes. There are increasing volumes of evidence that demonstrate that when you focus on the difference you make to patients, your commercial performance will improve. And, as other stakeholders adapt to the same economic conditions, driven by data and our ability to measure [ ]
One in three people will be diagnosed with cancer in their lifetime, but according to the NIH, only 3-5% of adult cancer patients participate in clinical trials. Advancing therapies in oncology and other disease areas is at the forefront of academic and commercial R D. But enrollment and site initiation is often hindered by daunting, time [ ]
How Properly Timed, Targeted Engagement Tactics can Increase Adherence and Brand Revenue Co-pay savings programs are powerful brand marketing tools; not just because of their ability to introduce new patients to therapy, but also due to the wealth of patient behavior data that they generate. These data, when used properly, can drive targeted patient engagement strategies that are uniquely [ ]
Ever wonder why 80% of clinical trials are delayed? The top reason is unfulfilled enrollment, and there are specific reasons why this happens with so many trials This webinar will reveal 5 patient enrollment errors that stall enrollment timelines in trial after trial. More importantly, it will provide useful advice, based on proven methods, for [ ]
Are you looking for a new opportunity? MicroMass Communications are behavior change specialists. Everyone from their writers to web developers plays a key role in developing solutions that have a powerful impact on the patients and providers they reach. Their collaborative culture, values, and emphasis on training and growth (not to mention their beer fridge) [ ]
Author: Marc Benjamin, CEO, Convergence Point Media Pharma marketing can sometimes feel like a thankless job, with the web of overlapping indications, “second plus”-line treatments, FDA regulations and privacy landmines sapping the joy out of even seasoned industry veterans. Even when you’ve seemingly overcome these obstacles and launched what you believed to be a campaign that [ ]
Evidera’s biannual publication addresses the scientific, strategic, and operational challenges of today’s healthcare environment, providing a forum for the exchange of thoughts and ideas focused on evidence and value. This issue is focused on Redefining Drug Development, highlighting the latest changes to regulations and guidelines, exploring the evolving needs in real-world and patient-centered evidence, and [ ]